Literature DB >> 2887561

Two types of transglutaminase in the PC12 pheochromocytoma cell line. Stimulation by sodium butyrate.

J C Byrd, U Lichti.   

Abstract

Transglutaminases are a class of enzymes capable of covalently cross-linking both intracellular and extracellular proteins. The activity of tissue transglutaminase is known to decrease precipitously following neoplastic transformation, and it has been hypothesized that transglutaminase may be involved in growth regulation. We have found that the differentiation promoter sodium butyrate is able to cause a marked increase in transglutaminase activity in PC12 pheochromocytoma cells in a time- and dose-dependent manner. This increased transglutaminase activity is associated with growth arrest, as well as with striking morphological changes including increased cell adhesion. The transglutaminase induced by sodium butyrate appears to be tissue transglutaminase, based on its cytosolic localization, thermal lability at basic pH, and elution profile on anion-exchange chromatography. Untreated PC12 cells contain only small amounts of transglutaminase which resembles epidermal transglutaminase, an enzyme previously described only in skin. In contrast to sodium butyrate, nerve growth factor did not stimulate tissue transglutaminase in PC12 cells, although it, too, caused growth arrest. It is hypothesized that transglutaminase may be involved in certain morphological changes accompanying cellular differentiation and neoplastic transformation, rather than in growth regulation per se.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2887561

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  "Tissue" transglutaminase is specifically expressed in neonatal rat liver cells undergoing apoptosis upon epidermal growth factor-stimulation.

Authors:  M Piacentini; F Autuori; L Dini; M G Farrace; L Ghibelli; L Piredda; L Fesus
Journal:  Cell Tissue Res       Date:  1991-02       Impact factor: 5.249

2.  Identification of cis-acting sequences in the promoter of the herpes simplex virus type 1 latency-associated transcripts required for activation by nerve growth factor and sodium butyrate in PC12 cells.

Authors:  D P Frazier; D Cox; E M Godshalk; P A Schaffer
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

3.  Regulation of the expression of the tissue transglutaminase gene by DNA methylation.

Authors:  S Lu; P J Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

4.  Bovine aortic endothelial cell transglutaminase. Enzyme characterization and regulation of activity.

Authors:  G Korner; D E Schneider; M A Purdon; T D Bjornsson
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

5.  Purification and characterization of a cytosolic transglutaminase from a cultured human tumour-cell line.

Authors:  C Y Dadabay; L J Pike
Journal:  Biochem J       Date:  1989-12-15       Impact factor: 3.857

6.  The herpes simplex virus type 1 latency-associated transcript promoter is activated through Ras and Raf by nerve growth factor and sodium butyrate in PC12 cells.

Authors:  D P Frazier; D Cox; E M Godshalk; P A Schaffer
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

7.  Differential expression of tissue transglutaminase in human cells. An immunohistochemical study.

Authors:  V Thomázy; L Fésüs
Journal:  Cell Tissue Res       Date:  1989-01       Impact factor: 5.249

8.  Sodium butyrate increases glucose transporter expression in LLC-PK1 cells.

Authors:  M Takano; D B Rhoads; K J Isselbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

9.  Immunological characterization and activity of transglutaminases in human normal and malignant prostate and in prostate cancer cell lines.

Authors:  B Friedrichs; H Riedmiller; H W Goebel; U Rausch; G Aumüller
Journal:  Urol Res       Date:  1995

10.  Association of a transglutaminase-related antigen with intermediate filaments.

Authors:  A V Trejo-Skalli; P T Velasco; S N Murthy; L Lorand; R D Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.